Ionic Liquid Assisted Green Synthesis of Quinoxaline Based Bisspirooxindoles: Anticancer Evaluation and Molecular Dynamics

IF 1.9 4区 化学 Q3 CHEMISTRY, MULTIDISCIPLINARY
Madhu Kanchrana, Gamidi Rama Krishna, Biswajit Dey, Nandita Pandey, Santosh Kumar Guru, Akanksha Ashok Sangolkar, Ravinder Pawar, Srinivas Basavoju
{"title":"Ionic Liquid Assisted Green Synthesis of Quinoxaline Based Bisspirooxindoles: Anticancer Evaluation and Molecular Dynamics","authors":"Madhu Kanchrana,&nbsp;Gamidi Rama Krishna,&nbsp;Biswajit Dey,&nbsp;Nandita Pandey,&nbsp;Santosh Kumar Guru,&nbsp;Akanksha Ashok Sangolkar,&nbsp;Ravinder Pawar,&nbsp;Srinivas Basavoju","doi":"10.1002/slct.202403608","DOIUrl":null,"url":null,"abstract":"<p>In this study, we have synthesized a series of novel quinoxaline based bisspirooxindoles through green protocol using ionic liquid [Bmim]BF<sub>4</sub>. All the compounds were well characterized by spectroscopic methods like FT-IR, <sup>1</sup>H NMR, <sup>13</sup>C NMR, mass and finally the structures were authenticated by single crystal X-ray diffraction (SCXRD) (<b>4e</b>). The target compounds were evaluated for their anticancer activity with different cancer cell lines like MDAMB-231, MCF-7, MCF-10A, HCC-1395, Molt-4, and FaDU. The compounds <b>4d</b>, <b>4g</b>, <b>4m,</b> and <b>4n</b> showed 42.0%, 43.3%, 52.7%, and 56.0 percentage of growth inhibition respectively with the T cell acute lymphoblastic Molt-4 cell line. The compounds <b>4b</b>, <b>4c</b>, <b>4</b> <b>h</b>, <b>4k,</b> and <b>4m</b> have shown 30%–39% of growth inhibition against FaDU cell line. Further, anticancer activity was validated with in silico molecular docking and molecular dynamics simulations. The outcomes of dynamics simulations exclusively emphasize that the compounds bind to HIS<sup>862</sup> and TYR<sup>896</sup> residues which are among the catalytic triad of PARP1. Finally, the results of ADME is also used to assess the drug likeness, which clearly shows that our target compounds are adaptable as potential drug pathways for medicinal chemists.</p>","PeriodicalId":146,"journal":{"name":"ChemistrySelect","volume":"9 42","pages":""},"PeriodicalIF":1.9000,"publicationDate":"2024-11-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"ChemistrySelect","FirstCategoryId":"92","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/slct.202403608","RegionNum":4,"RegionCategory":"化学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"CHEMISTRY, MULTIDISCIPLINARY","Score":null,"Total":0}
引用次数: 0

Abstract

In this study, we have synthesized a series of novel quinoxaline based bisspirooxindoles through green protocol using ionic liquid [Bmim]BF4. All the compounds were well characterized by spectroscopic methods like FT-IR, 1H NMR, 13C NMR, mass and finally the structures were authenticated by single crystal X-ray diffraction (SCXRD) (4e). The target compounds were evaluated for their anticancer activity with different cancer cell lines like MDAMB-231, MCF-7, MCF-10A, HCC-1395, Molt-4, and FaDU. The compounds 4d, 4g, 4m, and 4n showed 42.0%, 43.3%, 52.7%, and 56.0 percentage of growth inhibition respectively with the T cell acute lymphoblastic Molt-4 cell line. The compounds 4b, 4c, 4 h, 4k, and 4m have shown 30%–39% of growth inhibition against FaDU cell line. Further, anticancer activity was validated with in silico molecular docking and molecular dynamics simulations. The outcomes of dynamics simulations exclusively emphasize that the compounds bind to HIS862 and TYR896 residues which are among the catalytic triad of PARP1. Finally, the results of ADME is also used to assess the drug likeness, which clearly shows that our target compounds are adaptable as potential drug pathways for medicinal chemists.

Abstract Image

离子液体辅助绿色合成喹喔啉基双螺吲哚:抗癌评估与分子动力学
在本研究中,我们采用离子液体 [Bmim]BF4 通过绿色工艺合成了一系列新型喹喔啉基双螺吲哚。通过傅立叶变换红外光谱(FT-IR)、1H NMR、13C NMR、质量等光谱方法对所有化合物进行了表征,最后通过单晶 X 射线衍射(SCXRD)对其结构进行了鉴定(4e)。目标化合物的抗癌活性在不同的癌细胞系中进行了评估,如 MDAMB-231、MCF-7、MCF-10A、HCC-1395、Molt-4 和 FaDU。化合物 4d、4g、4m 和 4n 对 T 细胞急性淋巴细胞 Molt-4 细胞株的生长抑制率分别为 42.0%、43.3%、52.7% 和 56.0%。化合物 4b、4c、4h、4k 和 4m 对 FaDU 细胞株的生长抑制率为 30%-39%。此外,抗癌活性还得到了分子对接和分子动力学模拟的验证。动力学模拟的结果表明,这些化合物与 PARP1 催化三元组中的 HIS862 和 TYR896 残基结合。最后,ADME 的结果也用于评估药物的相似性,这清楚地表明我们的目标化合物可以作为药物化学家的潜在药物途径。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
ChemistrySelect
ChemistrySelect Chemistry-General Chemistry
CiteScore
3.30
自引率
4.80%
发文量
1809
审稿时长
1.6 months
期刊介绍: ChemistrySelect is the latest journal from ChemPubSoc Europe and Wiley-VCH. It offers researchers a quality society-owned journal in which to publish their work in all areas of chemistry. Manuscripts are evaluated by active researchers to ensure they add meaningfully to the scientific literature, and those accepted are processed quickly to ensure rapid online publication.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信